-
Severe Worsening in MS Disability After Stopping Gilenya Rare But Possible, FDA Warns
In a safety alert, the FDA warns of a rare risk of severe disability worsening among relapsing MS patients within weeks or months of stopping Gilenya’s use. Learn more here.
Had you heard about this warning? Does this news impact you personally?
Sorry, there were no replies found.
Log in to reply.